IP Library Granted Patent US 9,457,060
Granted Patent B2
US 9,457,060 · App. 11/479,481 · Granted Oct 4, 2016

Therapeutic methods using cyclosporine components

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,457,060
App. No.
11/479,481
Granted
Oct 4, 2016
Kind
B2
Abstract

Methods of treating humans or animals having various conditions are disclosed which include administering a cyclosporine component. Among the conditions treated are dry mouth syndrome, verruciform xanthoma, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, cancer of the oral mucosa, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter pylori infection, duodenal ulcers, peptic ulcers, conditions affecting the uterus and appendicitis.

Claims (3)

1. A method of treating a mucin deficiency of mucosal tissue, the method comprising:

topically administering to mucosal tissue of the genito-urinary tract of a human or animal having a mucin deficiency, a cream composition comprising cyclosporin A, or salts of cyclosporin A, in an amount of about 0.1% by weight to about 0.2% by weight; and

treating the mucin deficiency of mucosal tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2017
From: ALLERGAN, INC.
To: SAINT REGIS MOHAWK TRIBE
Reel/Frame 043830/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2006
From: STERN, MICHAEL E.; POWER, DAVID
To: ALLERGAN, INC.
Reel/Frame 018033/0790 →